Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Certolizumab pegol therapy"'
Publikováno v:
American Journal of Gastroenterology. 115:S1213-S1213
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92e35fcf062ec745c4dded2d62c47bc0
https://doi.org/10.14309/01.ajg.0000711228.59601.0a
https://doi.org/10.14309/01.ajg.0000711228.59601.0a
Autor:
Leonardo Guizzetti, Brian G. Feagan, William J. Sandborn, Niels Vande Casteele, Mohamed Yassine, Pavine Lefevre, Anca Pop
Publikováno v:
Inflammatory Bowel Diseases. 26:S69-S70
Background Certolizumab pegol (CZP) is effective treatment for moderately-to-severely active Crohn’s disease (CD)1, 2 at approved subcutaneous doses of 400 mg on weeks 0, 2 and 4 (induction) and every 4 weeks thereafter (maintenance). Prior researc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3014c5ee91af93c139219caa0ed345d2
https://doi.org/10.1093/ibd/zaa010.177
https://doi.org/10.1093/ibd/zaa010.177
Publikováno v:
Drug Development Research. 72:603-614
First-line treatment for moderate to severe rheumatoid arthritis (RA) has been the use of disease-modifying anti-rheumatic drugs (DMARDs), e.g., methotrexate. Because of the cases of failure reported to respond to available treatments, newer RA drugs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d8f4776e2060d33579d17d8fa21bf7d
https://doi.org/10.1002/ddr.20470
https://doi.org/10.1002/ddr.20470
Autor:
R.M. Flipo, B. Combe, J. Schuller, A. Saraux, G. Cukierman, Francis Fagnani, Jacques Massol, Jean-Michel Joubert
Publikováno v:
Value in Health. 21:S301
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04f12b5a7621ac8b39235de8c21b7198
https://doi.org/10.1016/j.jval.2018.09.1791
https://doi.org/10.1016/j.jval.2018.09.1791
Autor:
R.M. Flipo, Jean-Michel Joubert, A. Saraux, G. Cukierman, I. Bru, Francis Fagnani, J. Dunkel, Bernard Combe, W. Czarlewski, Jacques Massol
Publikováno v:
Value in Health
Value in Health, Elsevier, 2015, 18 (7), pp.A637. ⟨10.1016/j.jval.2015.09.2265⟩
Value in Health, Elsevier, 2015, 18 (7), pp.A637. ⟨10.1016/j.jval.2015.09.2265⟩
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a186d7bcb5f5f0ce4b6abb87437b8a2
https://hal.umontpellier.fr/hal-01901128
https://hal.umontpellier.fr/hal-01901128
Autor:
Scott D. Lee, Gordana Kosutic, Cem Kayhan, Ziad Younes, Iram Hasan, Theadore Ptak, Ira Shafran, Marshall Spearman, Jason Coarse, Philip B. Miner, William J. Sandborn
Publikováno v:
American Journal of Gastroenterology. 110:S774-S775
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8a13bd7e4fc82f7895a7b7f45712408
https://doi.org/10.14309/00000434-201510001-01821
https://doi.org/10.14309/00000434-201510001-01821
Autor:
Yuji Hirano, Atsushi Kaneko, Yasuhide Kanayama, Yosuke Hattori, Naoko Ishiguro, Nobunori Takahashi, T. Kato, Nobuyuki Asai, Toshihisa Kojima
Publikováno v:
Annals of the Rheumatic Diseases. 75:1015.2-1016
Background Certolizumab pegol (CZP) is a polyethylene glycol (PEG)ylated Fc-free new anti-TNF α agent. However few data still reported clinical efficacy of CZP treatment in the routine practice. Objectives To evaluate the clinical efficacy of CZP in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f9a74a45b7cc043ad37d9961e1f9de9
https://doi.org/10.1136/annrheumdis-2016-eular.3146
https://doi.org/10.1136/annrheumdis-2016-eular.3146
Autor:
Gordana Kosutic, Ziad Younes, Jason Coarse, Reena Khanna, William J. Sandborn, Marla Dubinsky, Iram Hasan, Scott Lee, Anita Afzali, Brian G. Feagan, Gerry Parker, Ira Shafran, Marshall Spearman, Theodore Ptak
Publikováno v:
Inflammatory Bowel Diseases. 22:S41
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84caed427b1953091f84576b6919c37e
https://doi.org/10.1097/01.mib.0000480206.37277.e8
https://doi.org/10.1097/01.mib.0000480206.37277.e8
Autor:
Janek Binek, Pierre Michetti, Michael Manz, P. De Saussure, Gerhard Rogler, A Schöpfer, Frank Seibold, G Bansky, Martin Geyer, Bernhard Sauter, Stephan R. Vavricka, Alex Straumann, Christian Felley, Michael Scharl
Publikováno v:
Zeitschrift für Gastroenterologie. 48
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2719d9d6c0ac58c9d8c139e47bf9db17
https://doi.org/10.1055/s-0030-1263685
https://doi.org/10.1055/s-0030-1263685
Autor:
Paul S. Tlucek, Donald U. Stone
Publikováno v:
Cornea. 31:90-91
To report the successful treatment of rheumatoid arthritis (RA)-associated scleritis with the tumor necrosis factor alpha antagonist certolizumab pegol.Retrospective case report of therapeutic interventions for a 47-year-old woman with scleritis and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9a448aeecf0d885ceb6bb332ed66225
https://doi.org/10.1097/ico.0b013e318211400a
https://doi.org/10.1097/ico.0b013e318211400a